CompletedPhase 1NCT01708720

Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pauline Verdijk
Principal Investigator
Pauline Verdijk, PhD
Institute for Public Health and the Environment
Intervention
IPV(drug)
Enrollment
45 target
Eligibility
18-49 years · MALE
Timeline
2011 – 2012

Study locations (1)

Collaborators

World Health Organization

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01708720 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis →

← Back to all trials